Zhong Huijuan

$8.56B
$236.1M (-2.7%)
as of 07/02/24

About Zhong Huijuan

Zhong Huijuan chairs Chinese drugmaker Hansoh Pharmaceutical, which produces oncology, psychoactive, antidiabetic and other drugs.

Zhong's husband, Sun Piaoyang, is also a pharmaceuticals billionaire and leads Shanghai-listed Jiangsu Hengrui Medicine.

Zhong owns nearly two-thirds of Hansoh Pharmaceutical with their daughter, Sun Yuan.

Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in June 2019.

Hansoh partnered to develop an oral Covid treatment with Bill & Melinda Gates Foundation-backed Global Health Drug Discovery Institute in October 2022.

Personal stats

Citizenship

People's Republic of China

Source of wealth

Pharmaceuticals

Residence

Shanghai, People's Republic of China

Marital status

Married

Birth date

01/01/61 (age 63)

Number of children

1

Education

Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing University

Self-made

self-made

Zhong Huijuan’s fortune is worth

143K

troy ounces of gold

132K

median U.S. household

86K

median U.S. income

0.171%

U.S. credit card volume

0.034%

GDP of the United States

0.025%

United States debt

Net worth history

Annual ranking

Net worth over time

Real-time ranking

Financial assets

HONG KONG | 3692-HK

Hansoh Pharmaceutical Group

SHANGHAI | 600276-CN

Jiangsu Hengrui Medicine

Images © Forbes.com. All rights reserved.